MedTrace Logo

Effect of Glucose 5% on Labor Length

NCT04492150 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 476

Last updated 2020-07-30

No results posted yet for this study

Summary

Induction of labor, is one of the most common obstetric procedures done routinely in modern obstetrics. For example, in USA, 23% of pregnant women in 2012 (about 1 million) underwent an induction of labor. However, accurate data about percentage of women undergoing induction of labor in Egypt is not accurately known.

One of the recent research era in current obstetrics is the optimal intravenous (IV) hydration of the pregnant women in labor.Current evidences available in our hands, suggest that maternal hydration appears to fasten labor progress and enhance the action of oxytocin, if the later is used for augmentation. However, the addition of glucose supplementation to this IV hydration to enhance uterine contraction, as a matter of safety and efficacy, is controversial

Conditions

  • Induction of Labor Affected Fetus / Newborn

Interventions

DRUG

Dextrose 5%/Nacl 0.3% Inj_#3

250 mL/hour of dextrose 5% intravenous drip

DRUG

Saline

250 mL/hour of normal saline intravenous drip

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Zakia M Ibraheim, MD · Professor of Gynecology and Obstetrics

  • Mariam L Mohammed, MD · Assistant Professor of Gynecology and Obstetrics

  • Hanan M Ghoneim, MD · Assistant Professor of Gynecology and Obstetrics

  • Ahmed M Abbas, MD · Assistant Professor of Gynecology and Obstetrics

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2020-09-10
Completion
2020-10-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492150 on ClinicalTrials.gov